Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 52 min ago
Peer-reviewedCC BY-NC-ND 4.0Mediastinum

AB024. Mixed histology is a prognostic factor for recurrence in completely resected thymic epithelial tumours: a multicentre retrospective study

2 more authors
8 affiliations
  1. 1Department of Pathology and Clinical Bioinformatics, Erasmus Medical Centre, Rotterdam, The Netherlands
  2. 2Department of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands
  3. 3Department of Respiratory Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands
  4. 4Department of Pulmonology, Maastricht UMC+, Maastricht, the Netherlands
  5. 5Department of Pathology, Maastricht UMC+, Maastricht, the Netherlands
  6. 6Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
  7. 7Department of Pathology, Centre Hospitalier Universitaire de Lyon, Lyon, France
  8. 8Department of Medical Oncology, Curie Institute, Paris, France

Abstract

Background: The recurrence of thymic epithelial tumours (TETs) following complete resection remains unpredictable. While the Masaoka-Koga staging system and WHO subtype classification are useful for clinical decision-making, no externally validated prognostic model exists to inform risk-adapted follow-up. Tumours with composite histological patterns, such as B2+B3 or B3+TC, are usually classified by their dominant subtype, potentially underestimating their aggressiveness. This study aimed to determine whether a machine learning (ML) model using these routine pathological variables could predict recurrence in completely resected TETs and whether including mixed histology would improve risk stratification.

Methods: Clinical data were collected from four centres (EMC, UMC+, TCGA and HCL). Patients with R1/R2 resection or stage IV disease were excluded. An internal development cohort (EMC (n=89), UMC+ (n=102), TCGA (n=116) and a geographically independent external validation cohort (HCL, n=95) were defined. A binary variable was introduced to identify tumours presenting two or more WHO subtypes. Six ML algorithms were evaluated and explainability was ensured through SHAP-based feature attribution.

Results: Patients with mixed histology had a recurrence rate of 18.5% (5/27) compared to 5.1% (14/277) in single-subtype cases (χ²=5.49, P=0.02). Among the six algorithms, Random Forest achieved the most consistent performance, with a balanced accuracy (BAcc) of 0.73 and Area Under the Curve (AUC) of 0.73 on the internal development cohort and a BAcc of 0.73, AUC of 0.72 and sensitivity of 0.80 on the external validation cohort. Ablation analysis confirmed the independent contribution of the mixed subtype indicator, as its removal reduced specificity by 0.03 and 0.08 in the internal and external cohorts respectively. SHAP analysis revealed that Masaoka-Koga stage IIb and subtype B2 had the highest feature importance, partly reflecting their prevalence in the dataset. Importantly, the overall pattern was consistent with established clinical knowledge, that aggressive subtypes and higher stages driving recurrence and indolent subtypes acting as protective, suggesting the model learned authentic clinicopathological relationships.

Conclusions: We developed an interpretable, externally validated model built on routine pathology data achieved clinically meaningful recurrence prediction in completely resected TETs. Our results support formal recognition of mixed histological subtypes as an independent risk factor and their inclusion in pathology may improve postoperative risk stratification.

Related

  1. Burr-Hole Intersection of Middle Meningeal Artery Branches and Recurrence in Chronic Subdural Haematoma: a Multicentre Retrospective Cohort Study
    T. M. Saba, J. Moudgil-Joshi, A. S. Pandit +4
    medRxivPreprintAll rights reservedFull textSurgery & anaesthesiamedRxiv
  2. AB025. Deep learning model predicts recurrence in thymic epithelial tumours: a multicentre study
    Anna Salut Esteve Domínguez, Stéphanie Peeters, Marlou Dimmers +11
    MediastinumPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
  3. AB040. Outcomes and prognostic factors in thymic epithelial tumors: a Brazilian retrospective cohort
    Alice S. de Souza, Viviane S. F. Silva, Viviane P. B. de Souza +6
    MediastinumPeer-reviewedCC BY-NC-ND 4.0Full textNeurologyPMC
  4. AB037. A three-indicator predictive model for postoperative pleural dissemination in completely resected thymic epithelial tumors
    Zheng Han, Yongqiang Ao, Mingyu Xia +7
    MediastinumPeer-reviewedCC BY-NC-ND 4.0Full textNeurologyPMC
  5. Adjuvant alectinib versus crizotinib in completely resected ALK-positive non-small-cell lung cancer: a real-world retrospective cohort study
    Translational Lung Cancer ResearchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
BibTeX
@article{dominguez2026ab024,
  title = {{AB024. Mixed histology is a prognostic factor for recurrence in completely resected thymic epithelial tumours: a multicentre retrospective study}},
  author = {Anna Salut Esteve Domínguez and Stéphanie Peeters and Marlou Dimmers and Daphne Dumoulin and Florit Marcuse and Myrurgia Abdul-Hamid and Rianne Fijten and Yunlei Li and Andrew Stubbs and Dirk De Ruysscher and Lara Chalabreysse and Nicolas Girard and Jan von der Thüsen and Farhan Akram},
  journal = {Mediastinum},
  year = {2026},
  month = oct,
  doi = {10.21037/med-26-ab024},
  url = {https://doi.org/10.21037/med-26-ab024},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - AB024. Mixed histology is a prognostic factor for recurrence in completely resected thymic epithelial tumours: a multicentre retrospective study
AU  - Anna Salut Esteve Domínguez
AU  - Stéphanie Peeters
AU  - Marlou Dimmers
AU  - Daphne Dumoulin
AU  - Florit Marcuse
AU  - Myrurgia Abdul-Hamid
AU  - Rianne Fijten
AU  - Yunlei Li
AU  - Andrew Stubbs
AU  - Dirk De Ruysscher
AU  - Lara Chalabreysse
AU  - Nicolas Girard
AU  - Jan von der Thüsen
AU  - Farhan Akram
PY  - 2026
DA  - 2026/10/30
JO  - Mediastinum
DO  - 10.21037/med-26-ab024
UR  - https://doi.org/10.21037/med-26-ab024
AB  - Background: The recurrence of thymic epithelial tumours (TETs) following complete resection remains unpredictable. While the Masaoka-Koga staging system and WHO subtype classification are useful for clinical decision-making, no externally validated prognostic model exists to inform risk-adapted follow-up. Tumours with composite histological patterns, such as B2+B3 or B3+TC, are usually classified by their dominant subtype, potentially underestimating their aggressiveness. This study aimed to determine whether a machine learning (ML) model using these routine pathological variables could predict recurrence in completely resected TETs and whether including mixed histology would improve risk stratification.  Methods: Clinical data were collected from four centres (EMC, UMC+, TCGA and HCL). Patients with R1/R2 resection or stage IV disease were excluded. An internal development cohort (EMC (n=89), UMC+ (n=102), TCGA (n=116) and a geographically independent external validation cohort (HCL, n=95) were defined. A binary variable was introduced to identify tumours presenting two or more WHO subtypes. Six ML algorithms were evaluated and explainability was ensured through SHAP-based feature attribution.  Results: Patients with mixed histology had a recurrence rate of 18.5% (5/27) compared to 5.1% (14/277) in single-subtype cases (χ²=5.49, P=0.02). Among the six algorithms, Random Forest achieved the most consistent performance, with a balanced accuracy (BAcc) of 0.73 and Area Under the Curve (AUC) of 0.73 on the internal development cohort and a BAcc of 0.73, AUC of 0.72 and sensitivity of 0.80 on the external validation cohort. Ablation analysis confirmed the independent contribution of the mixed subtype indicator, as its removal reduced specificity by 0.03 and 0.08 in the internal and external cohorts respectively. SHAP analysis revealed that Masaoka-Koga stage IIb and subtype B2 had the highest feature importance, partly reflecting their prevalence in the dataset. Importantly, the overall pattern was consistent with established clinical knowledge, that aggressive subtypes and higher stages driving recurrence and indolent subtypes acting as protective, suggesting the model learned authentic clinicopathological relationships.  Conclusions: We developed an interpretable, externally validated model built on routine pathology data achieved clinically meaningful recurrence prediction in completely resected TETs. Our results support formal recognition of mixed histological subtypes as an independent risk factor and their inclusion in pathology may improve postoperative risk stratification.
SN  - 2522-6711
ER  -